Imperato-McGinley, J., Shackleton, C., Orlic, S., & Stoner, E. (1990). C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: Comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. The journal of clinical endocrinology and metabolism, 70(3), 777. https://doi.org/10.1210/jcem-70-3-777
Chicago Style (17th ed.) CitationImperato-McGinley, J., C. Shackleton, S. Orlic, and E. Stoner. "C19 and C21 5 Beta/5 Alpha Metabolite Ratios in Subjects Treated with the 5 Alpha-reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5 Alpha-reductase Deficiency." The Journal of Clinical Endocrinology and Metabolism 70, no. 3 (1990): 777. https://doi.org/10.1210/jcem-70-3-777.
MLA (9th ed.) CitationImperato-McGinley, J., et al. "C19 and C21 5 Beta/5 Alpha Metabolite Ratios in Subjects Treated with the 5 Alpha-reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5 Alpha-reductase Deficiency." The Journal of Clinical Endocrinology and Metabolism, vol. 70, no. 3, 1990, p. 777, https://doi.org/10.1210/jcem-70-3-777.